DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Jefferies Initiates Coverage On Ocular Therapeutix with Buy Rating, Announces $8 Price Target

Jefferies analyst David Steinberg initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy rating and a $8 price target.

Benzinga · 03/17/2020 14:22

Jefferies analyst David Steinberg initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy rating and a $8 price target.